Humanized neuraminidase antibody and methods of use thereof
First Claim
Patent Images
1. An isolated monoclonal antibody that binds neuraminidase, wherein the antibody has the ability to inhibit neuraminidase enzyme activity, and wherein the antibody comprises the light chain variable region amino acid sequence as set forth in amino acids 1 to 127 of SEQ ID NO:
- 5, and the heavy chain variable region amino acid sequence as set forth in amino acids 1 to 137 of SEQ ID NO;
6.
2 Assignments
0 Petitions
Accused Products
Abstract
Antibodies against influenza neuraminidase, compositions containing the antibodies, and methods of using the antibodies are provided herein.
-
Citations
24 Claims
-
1. An isolated monoclonal antibody that binds neuraminidase, wherein the antibody has the ability to inhibit neuraminidase enzyme activity, and wherein the antibody comprises the light chain variable region amino acid sequence as set forth in amino acids 1 to 127 of SEQ ID NO:
- 5, and the heavy chain variable region amino acid sequence as set forth in amino acids 1 to 137 of SEQ ID NO;
6. - View Dependent Claims (5)
- 5, and the heavy chain variable region amino acid sequence as set forth in amino acids 1 to 137 of SEQ ID NO;
-
2. An antigen-binding fragment of an antibody that binds neuraminidase and has the ability to inhibit neuraminidase enzyme activity, wherein the antigen-binding fragment comprises a light chain variable region comprising the amino acid sequence set forth in amino acids 1 to 127 of SEQ ID NO:
- 5, and a heavy chain variable region comprising the amino acid sequence set forth in amino acids 1 to 137 of SEQ ID NO;
6. - View Dependent Claims (3, 4)
- 5, and a heavy chain variable region comprising the amino acid sequence set forth in amino acids 1 to 137 of SEQ ID NO;
-
6. An antibody that binds neuraminidase, wherein the antibody has the ability to inhibit neuraminidase enzyme activity, and wherein the antibody comprises the light chain amino acid sequence set forth in SEQ ID NO:
- 9 or SEQ ID NO;
10 or the light chain amino acid sequence set forth in SEQ ID NO;
9 or SEQ ID NO;
10 with conservative substitutions such that it is at least 95 percent identical to the amino acid sequence set forth in SEQ ID NO;
9 or SEQ ID NO;
10, and wherein the antibody comprises the heavy chain amino acid sequence set forth in SEQ ID NO;
7 or SEQ ID NO;
8 or the heavy chain amino acid sequence set forth in SEQ ID NO;
7 or SEQ ID NO;
8 with conservative substitutions such that it is at least 95 percent identical to the amino acid sequence set forth in SEQ ID NO;
7 or SEQ ID NO;
8. - View Dependent Claims (7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
- 9 or SEQ ID NO;
Specification